These results are particularly intriguing in light of research showing that the expression level of LL-37 in patients with leukemia is significantly reduced (An et al. 2005), which may affect not only tumor progression, but also resistance to infections in patients diagnosed with leukemia. The gene discussed is CAMP; the disease is leukemia.